Literature DB >> 43786

Prolactin release by intravenous cimetidine in man: evidence for a suprapituitary locus on action.

C Ferrari, R Caldara, C Barbieri, M Cambielli, L Bierti, M Romussi.   

Abstract

In an attempt to identify the sites at which cimetidine stimulates prolactin release, the drug was administered intravenously (6 mg/kg body weight) to healthy subjects under basal conditions, during dopamine infusion (1 microgram/Kg-min for 120 min) and after pretreatment with L-dopa plus carbidopa (250 plus 25 mg every 6 for 1 day). The serum prolactin response to cimetidine was abolished by dopamine infusion and almost completely suppressed by L-dopa plus carbidopa administration. These findings suggest that the drug acts on the central nervous system to stimulate prolactin release. Although the mechanism of this action is unclear, it does not seem to depend on an antidopaminergic effect and may be related to blackade of brain H2 histamine receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43786     DOI: 10.1111/j.1365-2265.1979.tb03116.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Inhibition of cimetidine-induced hyperprolactinemia by pretreatment with metergoline.

Authors:  M Iodice; G Lombardi; A P Tommaselli; R Rossi; M Minozzi
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

Review 2.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

3.  Cimetidine and plasma levels of gonadotropins, prolactin and gonadal steroids in women.

Authors:  S Bélisle; M Patry; L Tétreault
Journal:  Can Med Assoc J       Date:  1982-07-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.